The genetics of cardiovascular disease

Padmanabhan, 2008, Hypertension and genome-wide association studies: combining high fidelity phenotyping and hypercontrols, J. Hypertens., 26, 1275, 10.1097/HJH.0b013e3282ff634f Dominiczak, 2005, Corcoran Lecture. Cardiovascular genomics and oxidative stress, Hypertension, 45, 636, 10.1161/01.HYP.0000154253.53134.09 Matsuzaki, 2004, Genotyping over 100,000 SNPs on a pair of oligonucleotide arrays, Nat. Methods, 1, 109, 10.1038/nmeth718 Gunderson, 2005, A genome-wide scalable SNP genotyping assay using microarray technology, Nat. Genet., 37, 549, 10.1038/ng1547 2007, Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls, Nature, 447, 661, 10.1038/nature05911 Samani, 2007, Genome-wide association analysis of coronary artery disease, N. Engl. J. Med., 357, 443, 10.1056/NEJMoa072366 Sandhu, 2008, LDL-cholesterol concentrations: a genome-wide association study, Lancet, 371, 483, 10.1016/S0140-6736(08)60208-1 Levy, 2007, Framingham Heart Study 100K Project: genome-wide associations for blood pressure and arterial stiffness, BMC Med. Genet., 8, S3, 10.1186/1471-2350-8-S1-S3 Kathiresan, 2008, Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans, Nat. Genet., 40, 189, 10.1038/ng.75 Wallace, 2008, Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia, Am. J. Hum. Genet., 82, 139, 10.1016/j.ajhg.2007.11.001 Diabetes Genetics Initiative of Broad Institute of Harvard and MIT et al. (2007) Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science. 316, 1331–1336 Caulfield, 2003, Genome-wide mapping of human loci for essential hypertension, Lancet, 361, 2118, 10.1016/S0140-6736(03)13722-1 Bowcock, 2007, Genomics: guilt by association, Nature, 447, 645, 10.1038/447645a McCarthy, 2008, Genome-wide association studies for complex traits: consensus, uncertainty and challenges, Nat. Rev. Genet., 9, 356, 10.1038/nrg2344 Chen, 2008, Variations in DNA elucidate molecular networks that cause disease, Nature, 452, 429, 10.1038/nature06757 Emilsson, 2008, Genetics of gene expression and its effect on disease, Nature, 452, 423, 10.1038/nature06758 Rapp, 2000, Genetic analysis of inherited hypertension in the rat, Physiol. Rev., 80, 135, 10.1152/physrev.2000.80.1.135 Cowley, 2004, Application of chromosomal substitution techniques in gene-function discovery, J. Physiol., 554, 46, 10.1113/jphysiol.2003.052613 2004, Genome sequence of the Brown Norway rat yields insights into mammalian evolution, Nature, 428, 493, 10.1038/nature02426 Hunt, 2004, The visual language of synteny, OMICS, 8, 289, 10.1089/omi.2004.8.289 Jakubowska, 2007, VisGenome: visualization of single and comparative genome representations, Bioinformatics, 23, 2641, 10.1093/bioinformatics/btm394 Mueller, 2006, eQTL Explorer: integrated mining of combined genetic linkage and expression experiments, Bioinformatics, 22, 509, 10.1093/bioinformatics/btk007 Aitman, 2008, Progress and prospects in rat genetics: a community view, Nat. Genet., 40, 516, 10.1038/ng.147 Dominiczak, 1996, Vascular smooth muscle polyploidy and cardiac hypertrophy in genetic hypertension, Hypertension, 27, 752, 10.1161/01.HYP.27.3.752 Conrad, 1991, Impaired myocardial function in spontaneously hypertensive rats with heart failure, Am. J. Physiol., 260, H136 Jeffs, 1997, Sensitivity to cerebral ischaemic insult in a rat model of stroke is determined by a single genetic locus, Nat. Genet., 16, 364, 10.1038/ng0897-364 Grunfeld, 1995, Role of superoxide in the depressed nitric oxide production by the endothelium of genetically hypertensive rats, Hypertension, 26, 854, 10.1161/01.HYP.26.6.854 Kerr, 1999, Superoxide anion production is increased in a model of genetic hypertension: the role of endothelial nitric oxide synthase and superoxide dismutase isoforms, Hypertension, 33, 1353, 10.1161/01.HYP.33.6.1353 Hamilton, 2001, Superoxide excess in hypertension and ageing: a common cause of endothelial dysfunction, Hypertension, 37, 529, 10.1161/01.HYP.37.2.529 Clark, 1996, Quantitative trait loci in genetically hypertensive rats, Hypertension, 28, 898, 10.1161/01.HYP.28.5.898 Jeffs, 2000, Applicability of a “speed” congenic strategy to dissect blood pressure quantitative trait loci on rat chromosome 2, Hypertension, 35, 179, 10.1161/01.HYP.35.1.179 Dutil, 2001, Further chromosomal mapping of a blood pressure QTL in Dahl rats on chromosome 2 using congenic strains, Physiol. Genomics, 6, 3, 10.1152/physiolgenomics.2001.6.1.3 Garrett, 2002, Multiple blood pressure QTL on rat chromosome 2 defined by congenic Dahl rats, Mamm. Genome, 13, 41, 10.1007/s00335-001-2114-y McBride, 2003, Microarray analysis of rat chromosome 2 congenic strains, Hypertension, 41, 847, 10.1161/01.HYP.0000047103.07205.03 McBride, 2005, Reduction of Gstm1 expression in the stroke-prone spontaneously hypertension rat contributes to increased oxidative stress, Hypertension, 45, 786, 10.1161/01.HYP.0000154879.49245.39 Graham, 2007, Candidate genes that determine response to salt in the stroke-prone spontaneously hypertensive rat: congenic analysis, Hypertension, 50, 1134, 10.1161/HYPERTENSIONAHA.107.095349 Petretto, 2008, Integrated genomic approaches implicate osteoglycin (Ogn) in the regulation of left ventricular mass, Nat. Genet., 40, 546, 10.1038/ng.134 Monti, 2008, Soluble epoxide hydrolase is a susceptibility factor for heart failure in a rat model of human disease, Nat. Genet., 40, 529, 10.1038/ng.129 Iwai, 2004, Genetic analysis of 22 candidate genes for hypertension in the Japanese population, J. Hypertens., 22, 1119, 10.1097/00004872-200406000-00012 Abu-Amero, 2006, T null and M null genotypes of the glutathione S-transferase gene are risk factor for CAD independent of smoking, BMC Med. Genet., 7, 38, 10.1186/1471-2350-7-38 Wilson, 2000, Glutathione S-transferase M1 null genotype is associated with a decreased risk of myocardial infarction, FASEB J., 14, 791, 10.1096/fasebj.14.5.791 Delles, 2008, Targeting reactive oxygen species in hypertension, Antioxid. Redox Signal., 10, 1061, 10.1089/ars.2007.2008 Hamilton, 2004, Strategies to reduce oxidative stress in cardiovascular disease, Clin. Sci. (Lond.), 106, 219, 10.1042/CS20030379 Roodi, 2004, Association of homozygous wild-type glutathione S-transferase M1 genotype with increased breast cancer risk, Cancer Res., 64, 1233, 10.1158/0008-5472.CAN-03-2861 Benhamou, 2002, Meta– and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk, Carcinogenesis, 23, 1343, 10.1093/carcin/23.8.1343 NCI-NHGRI Working Group on Replication in Association Studies et al. (2007) Replicating genotype–phenotype associations. Nature 447, 655–660 Delles, 2008, Glutathione S-transferase variants and hypertension, J. Hypertens., 26, 1343, 10.1097/HJH.0b013e3282fe1d67 Tobin, 2008, Common variants in genes underlying monogenic hypertension and hypotension and blood pressure in the general population, Hypertension, 51, 1658, 10.1161/HYPERTENSIONAHA.108.112664 Ji, 2008, Rare independent mutations in renal salt handling genes contribute to blood pressure variation, Nat. Genet., 40, 592, 10.1038/ng.118 Newhouse, 2005, Haplotypes of the WNK1 gene associate with blood pressure variation in a severely hypertensive population from the British Genetics of Hypertension study, Hum. Mol. Genet., 14, 1805, 10.1093/hmg/ddi187 Tobin, 2005, Association of WNK1 gene polymorphisms and haplotypes with ambulatory blood pressure in the general population, Circulation, 112, 3423, 10.1161/CIRCULATIONAHA.105.555474 Moreno, 2006, The C242T CYBA polymorphism of NADPH oxidase is associated with essential hypertension, J. Hypertens., 24, 1299, 10.1097/01.hjh.0000234110.54110.56 Guzik, 2000, Functional effect of the C242T polymorphism in the NAD(P)H oxidase p22phox gene on vascular superoxide production in atherosclerosis, Circulation, 102, 1744, 10.1161/01.CIR.102.15.1744 Delles, 2008, Vascular stiffness is related to superoxide generation in the vessel wall, J. Hypertens., 26, 946, 10.1097/HJH.0b013e3282f7677c Zalba, 2005, NADPH oxidase-dependent superoxide production is associated with carotid intima-media thickness in subjects free of clinical atherosclerotic disease, Arterioscler. Thromb. Vasc. Biol., 25, 1452, 10.1161/01.ATV.0000168411.72483.08 Sayed-Tabatabaei, 2006, ACE polymorphisms, Circ. Res., 98, 1123, 10.1161/01.RES.0000223145.74217.e7 Staessen, 2005, Adducin and hypertension, Pharmacogenomics, 6, 665, 10.2217/14622416.6.7.665 Teo, 2008, Common statistical issues in genome-wide association studies: a review on power, data quality control, genotype calling and population structure, Curr. Opin. Lipidol., 19, 133, 10.1097/MOL.0b013e3282f5dd77 Harrap, 2003, Where are all the blood-pressure genes?, Lancet, 361, 2149, 10.1016/S0140-6736(03)13694-X Klein, 2005, Complement factor H polymorphism in age-related macular degeneration, Science, 308, 385, 10.1126/science.1109557 Edwards, 2005, Complement factor H polymorphism and age-related macular degeneration, Science, 308, 421, 10.1126/science.1110189 Matarín, 2007, A genome-wide genotyping study in patients with ischaemic stroke: initial analysis and data release, Lancet Neurol., 6, 414, 10.1016/S1474-4422(07)70081-9 Matarín, 2008, Whole genome analyses suggest ischemic stroke and heart disease share an association with polymorphisms on chromosome 9p21, Stroke, 39, 1586, 10.1161/STROKEAHA.107.502963 Sharma, 2000, The future of genetic association studies in hypertension: improving the signal-to-noise ratio, J. Hypertens., 18, 811, 10.1097/00004872-200018070-00001 Oniki, 2008, Association between glutathione S-transferase A1, M1 and T1 polymorphisms and hypertension, Pharmacogenet. Genomics, 18, 275, 10.1097/FPC.0b013e3282f56176 Cupples, 2008, Family study designs in the age of genome-wide association studies: experience from the Framingham Heart Study, Curr. Opin. Lipidol., 19, 144, 10.1097/MOL.0b013e3282f73746 Pollex, 2007, Copy number variation in the human genome and its implications for cardiovascular disease, Circulation, 115, 3130, 10.1161/CIRCULATIONAHA.106.677591 Latronico, 2007, Emerging role of microRNAs in cardiovascular biology, Circ. Res., 101, 1225, 10.1161/CIRCRESAHA.107.163147 Good, 2007, Body fluid proteomics for biomarker discovery: lessons from the past hold the key to success in the future, J. Proteome Res., 6, 4549, 10.1021/pr070529w Zimmerli, 2008, Urinary proteomic biomarkers in coronary artery disease, Mol. Cell. Proteomics, 7, 290, 10.1074/mcp.M700394-MCP200 Padmanabhan, 2006, Chromosome 2p shows significant linkage to antihypertensive response in the British Genetics of Hypertension Study, Hypertension, 47, 603, 10.1161/01.HYP.0000197947.62601.9d Turner, 2003, Effects of endothelial nitric oxide synthase, α-adducin, and other candidate gene polymorphisms on blood pressure response to hydrochlorothiazide, Am. J. Hypertens., 16, 834, 10.1016/S0895-7061(03)01011-2 Bhatnagar, 2007, Angiotensin-converting enzyme gene polymorphism predicts the time-course of blood pressure response to angiotensin converting enzyme inhibition in the AASK trial, J. Hypertens., 25, 2082, 10.1097/HJH.0b013e3282b9720e